Khouri Charles

50PUBLICATIONS
66CO-AUTHORS
Pharmacology and pharmaceutical sciences not elsewhere classifiedBehavioural epidemiologyInstrumental methods (excl. immunological and bioassay methods)PharmacogenomicsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Jul 28, 2026
Redundant pharmacovigilance disproportionality analyses: Navigating between Scylla and Charybdis.

|Jun 10, 2026
Fenfluramine-associated pulmonary hypertension: a study of adverse events reporting system FAERS.

|May 05, 2026
Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance".

|Mar 20, 2026
[Assessing the risk-benefit balance of medicines: Some lessons from Covid-19].

Jean-Luc Cracowski, Mathieu Molimard, Vincent Richard

|Feb 12, 2026
Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.

Clément Jambon-Barbara, Samy Suissa, Sophie Dell'Aniello

|Jan 28, 2026
Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.

Victoria Toro, Manon Mougin, Coline Brossat

Pageof 9

Frequent Collaborators

12 joint publications

David Montani

9 joint publications

Roustit Matthieu

9 joint publications

Marc Humbert

7 joint publications

Marie-Camille Chaumais